BDBM498906 N-[(3S,4R)-3-{[4-(amino- methyl)benzyl]carbamoyl}- 1-(N~2~-cyclohexyl-D- lysyl)piperidin-4-yl]-6- azaspiro[2.5]octane-6- carboxamide::US11014920, Compound 14

SMILES NCCCC[C@@H](NC1CCCCC1)C(=O)N1CC[C@@H](NC(=O)N2CCC3(CC3)CC2)[C@H](C1)C(=O)NCc1ccc(CN)cc1

InChI Key InChIKey=VGKPQLMMXCSUQB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 498906   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM498906(N-[(3S,4R)-3-{[4-(amino- methyl)benzyl]carbamoyl}-...)
Affinity DataIC50: 18.7nMAssay Description:Factor XIIa activity determinations were made in 50 mM HEPES buffer containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2021
Entry Details
Go to US Patent